Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06951217

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Led by Avalyn Pharma Inc. · Updated on 2026-04-29

340

Participants Needed

52

Research Sites

349 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants will have their final dose of drug at the end of study visit from the lead-in study and first AP-LTE-008 study visit on the same day.

CONDITIONS

Official Title

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Previously participated in an Avalyn inhaled antifibrotic study for idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF) with approval of the study physician
  • Completed the final treatment visit on full dose of study drug (active or placebo) in the prior study
  • Male and female participants of childbearing potential must agree to use highly effective contraception from first dose or consent signing during the study and for 90 days after last dose
  • Agree not to donate eggs or sperm during the study and 90 days after last dose
Not Eligible

You will not qualify if you...

  • Did not previously participate in an Avalyn inhaled antifibrotic lead-in study or were permanently discontinued from it for any reason
  • Experienced exacerbation of asthma or COPD requiring oral/systemic corticosteroids within 3 months before screening
  • Experienced an acute exacerbation of IPF or PPF within 3 months before screening
  • Participated in another clinical study with investigational drugs (other than Avalyn nebulized antifibrotic) within 30 days or 5 half-lives before screening
  • History of allergic reaction to pirfenidone or study excipients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 52 locations

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35205

Actively Recruiting

2

University of Southern California

Los Angeles, California, United States, 90033

Actively Recruiting

3

University of Colorado, Anschutz Medical Campus

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Renstar Medical Research

Ocala, Florida, United States, 34470

Actively Recruiting

5

Piedmont Healthcare, Inc.

Atlanta, Georgia, United States, 30309

Actively Recruiting

6

University of Maryland

Baltimore, Maryland, United States, 21201

Actively Recruiting

7

Mayo Clinic Rochester

Rochester, Minnesota, United States, 55901

Actively Recruiting

8

Hannibal Regional Healthcare System, Inc.

Hannibal, Missouri, United States, 63401

Actively Recruiting

9

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

10

Columbia University

New York, New York, United States, 10032

Actively Recruiting

11

Piedmont HealthCare, PA

Statesville, North Carolina, United States, 28625

Actively Recruiting

12

Southeastern Research Center

Winston-Salem, North Carolina, United States, 27103

Actively Recruiting

13

University of Cincinnati

Cincinnati, Ohio, United States, 45267

Actively Recruiting

14

The University of Kansas Medical Center

Kansas, Ohio, United States, 66160

Actively Recruiting

15

Summit Health

Bend, Oregon, United States, 97701

Actively Recruiting

16

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

17

Temple University Hospital

Philadelphia, Pennsylvania, United States, 19140

Actively Recruiting

18

Lowcountry Lung and Critical Care, PA

Charleston, South Carolina, United States, 29406

Actively Recruiting

19

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

Actively Recruiting

20

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37204

Actively Recruiting

21

El Paso Pulmonary Association, P.A.

El Paso, Texas, United States, 79902

Actively Recruiting

22

Intermountain Medical Center

Murray, Utah, United States, 84107

Actively Recruiting

23

Inova Healthcare

Falls Church, Virginia, United States, 22042

Actively Recruiting

24

Westmead Hospital

Westmead, New South Wales, Australia, 2145

Actively Recruiting

25

The Queen Elizabeth Hospital

Woodville South, South Australia, Australia, 5011

Active, Not Recruiting

26

Royal Prince Alfred Hospital

Camperdown, Australia

Actively Recruiting

27

The Prince Charles Hospital (TPCH)

Chermside, Australia

Actively Recruiting

28

Lung & Sleep Victoria

Footscray, Australia

Actively Recruiting

29

Respiratory Clinical Trials PTY Ltd

Kent Town, Australia

Actively Recruiting

30

Nepean Lung & Sleep

Kingston, Australia

Actively Recruiting

31

Univ of Western Australia / Institute for Respiratory Health

Nedlands, Australia

Actively Recruiting

32

John Hunter Hospital

New Lambton Heights, Australia

Actively Recruiting

33

Dynamic Drug Advancement

Ajax, Ontario, Canada

Actively Recruiting

34

Research Institute McGill University Health Center

Montreal, Quebec, Canada, H4A 3J1

Actively Recruiting

35

CIC Mauricie

Trois-Rivières, Quebec, Canada, G8T 7A1

Actively Recruiting

36

Centre for Lung Health

Vancouver, Canada, V5Z1M9

Actively Recruiting

37

Fakultni Thomayerove nemocnice

Praha Klanovice, Czechia

Actively Recruiting

38

University of Montpellier

Montrevel-en-Bresse, Montpellier, France, 34090

Actively Recruiting

39

Centre Hospitalier Universitaire d'Angers

Angers, France, 49933

Actively Recruiting

40

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany, 30625

Actively Recruiting

41

Fondazione IRCCS Policlinico San Matteo - UOC Pneumologia

Pavia, Lombardy, Italy, 27100

Actively Recruiting

42

St Antonius Hospital

Nieuwegein, Netherlands

Actively Recruiting

43

Greenlane Clinical Centre

Auckland, New Zealand

Actively Recruiting

44

Dunedin Hospital

Dunedin, New Zealand, 9016

Active, Not Recruiting

45

Waikato Hospital

Hamilton, New Zealand

Actively Recruiting

46

Bay of Plenty Clinical Trials Unit

Tauranga, New Zealand, 3112

Actively Recruiting

47

Uniwersyteckie Centrum Kliniczne

Gdansk, Poland, 80211

Actively Recruiting

48

Department of Pneumology of the University Hospital No 1

Lodz, Poland, 90315

Actively Recruiting

49

Hospital Gregorio Marañon

Madrid, Spain

Actively Recruiting

50

Hull University Teaching Hospital

Cottingham, East Yorkshire, United Kingdom, HU16 5JQ

Actively Recruiting

51

Royal Papworth Hospital NHS Foundation Trust

Cambridge, United Kingdom, CB2 0AY

Actively Recruiting

52

Leicester Biomedical Research Centre

Leicester, United Kingdom

Actively Recruiting

Loading map...

Research Team

D

Dr. Felix Woodhead, MB BChir,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here